PeptidePedia The community reference

Contributions of FlowTrialFraser

User contributions·20 logged edits·page 1 of 1

Contributions by FlowTrialFraser, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 2,955 edits includes activity predating the current log.

  1. 18:00, 26 Jul 2026 (diff | hist) Thermo Fisher Scientific (China) 18,573 +220 add the note that this wiki publishes no score and no league table
  2. 09:45, 16 Mar 2026 (diff | hist) Talk:FLOW trial 400 +175 /* Early stopping inflates estimates */ new section
  3. 13:25, 25 Feb 2026 (diff | hist) Talk:LEADER trial 611 +116 /* Renal signal was a marker */ reply
  4. 06:52, 23 Feb 2026 (diff | hist) Shanghai Sigma-Audley New Material Technology 15,579 ±0 m add the standing talk-page note link to the banner
  5. 00:59, 22 Feb 2026 (diff | hist) Chain of custody 5,157 ±0 add the difference between a batch certificate and a lot-specific one
  6. 14:41, 2 Sep 2025 (diff | hist) Peptide synthesis 5,649 +682 add the note that lyophilised material tolerates excursions better than solution
  7. 03:13, 28 Aug 2025 (diff | hist) LEADER trial 4,799 +628 expand §Place in the evidence
  8. 00:58, 27 Aug 2025 (diff | hist) Preparative HPLC purification 4,882 ±0 attribute the stability figure to the study and its duration
  9. 04:09, 20 Aug 2025 (diff | hist) Cold-chain freight 4,370 ±0 add the data-logger point: an unlogged shipment has no excursion record
  10. 17:05, 15 Jun 2025 (diff | hist) TRIUMPH trial programme 4,035 ±0 expand §What phase 3 is designed to address
  11. 15:08, 20 May 2025 (diff | hist) Intention-to-treat analysis 4,637 +815 add the year of publication to each trial in the list
  12. 02:50, 22 Apr 2025 (diff | hist) Weight regain after discontinuation 4,031 ±0 m add the interaction with the mechanism that explains it
  13. 23:44, 17 Feb 2025 (diff | hist) Number needed to treat 3,631 +390 cite the trial publication rather than the sponsor press release
  14. 09:49, 2 Jan 2025 (diff | hist) Peptide harm reduction 2,752 +452 rm the advice on how to obtain coverage
  15. 04:24, 6 Dec 2024 (diff | hist) Intention-to-treat analysis 3,350 +34 the article attributed a finding to the wrong trial in the programme
  16. 00:13, 5 Dec 2024 (diff | hist) Sarcopenia 1,597 +424 add the sample-stability sentence with its storage condition
  17. 16:25, 20 Sep 2024 (diff | hist) LEADER trial 1,964 +844 consistent en dashes in ranges
  18. 19:51, 10 Sep 2024 (diff | hist) Injection site rotation 1,581 +1,581 N new article: dosing and handling, expansion welcome
  19. 09:00, 3 Sep 2024 (diff | hist) LEADER trial 1,120 +1,120 N new article: trial programme, expansion welcome
  20. 06:52, 31 Jul 2024 (diff | hist) Semaglutide 3,912 +734 add category for the drug class